NEWS
November 28, 2011 | By Jeannine Stein, Los Angeles Times / For the Booster Shots blog
Getting smokers to quit can be tough, but two studies reporting success with smoking-cessation programs released Monday in the journal Archives of Internal Medicine offer some hope. One study focused on using a practice quit-attempt program and nicotine therapy for smokers who weren't motivated to quit. Researchers worked with 849 people in a randomized trial; participants were assigned to a six-week practice quit-attempt program or a program that also included sampling nicotine lozenges to increase the impetus to quit.
NEWS
November 2, 2011 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
Nicotine appears to be a potent "gateway" drug that enhances the effects of cocaine and possibly boosts the chances of becoming addicted, researchers reported Wednesday in a landmark paper on drug addiction. While the study was performed in lowly mice, the findings suggest that reducing smoking and the use of other tobacco products -- and even nicotine replacement products and exposure to secondhand smoke -- in humans may have the bilateral impact of curbing addiction to other addictive substances.
NEWS
June 10, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
Some smokers won’t quit because they think they’ll gain weight if they do -- and statistically speaking, they’re probably right. But now that scientists have found nicotine receptors in the brains of mice that appear to influence appetite, there’s hope that researchers could eventually engineer a weight-loss drug that mimics nicotine. It just won't happen anytime soon. In the new study, scientists from Yale University and the Baylor College of Medicine investigated how nicotine worked in the brains of mice to suppress their appetite.
NEWS
May 17, 2011 | By Karen Kaplan, Los Angeles Times / For the Booster Shots blog
What makes nicotine so addictive? The answer to that question could help researchers develop a drug that would help smokers give up cigarettes for good. A study published online this week provides some useful clues. Researchers zeroed in on a particular gene called OPRM1. This gene contains instructions for building a type of receptor that allows opioids – including drugs like heroin and morphine as well as opioids produced inside the body – to make their presence known in the brain, triggering release of the feel-good chemical dopamine.
NEWS
February 9, 2011 | By Eryn Brown, Los Angeles Times
Two studies published online Tuesday by the American Journal of Preventive Medicine tell consumers more -- a little bit more, anyway -- about electronic cigarettes and their potential to help smokers cut back or quit the habit. Electronic cigarettes are built to look like real cigarettes. They're made of plastic, run on batteries and allow users to inhale nicotine in a vapor form. Unlike nicotine delivery products such as gum, lozenges or patches, or smoking cessation medications like Chantix, they allow users to hold something that feels like a cigarette and mimic the behavior of smoking.
NEWS
January 7, 2011 | By Amina Khan, Los Angeles Times
By late March, tobacco companies will have to reveal to the Food and Drug Administration what sorts of new additives they've recently put in their products. But the ruling doesn't apply to electronic cigarettes, whose makers are locked in legal battle with the FDA. Meanwhile, the e-cigs are starting to gain a pop-culture foothold – in the fall film “The Tourist,” actor Johnny Depp extols the devices’ virtues to Angelina Jolie, and Katherine Heigl showed up recently on the "Late Show with David Letterman" smoking the e-cigarette indoors.